SIO GENE THERAPIES - Trademark Details
Status: 686 - Published For Opposition
Serial Number
90340409
Word Mark
SIO GENE THERAPIES
Status
686 - Published For Opposition
Status Date
2021-12-28
Filing Date
2020-11-24
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
260121, 260129, 260131, 261701, 261705 - Circles that are totally or partially shaded. Helixes. Five or more circles. Straight line(s), band(s) or bar(s). Horizontal line(s), band(s) or bar(s).
Published for Opposition Date
2021-12-28
Attorney Name
Law Office Assigned Location Code
L50
Employee Name
LAPTER, ALAIN J
Statements
Disclaimer with Predetermined Text
"GENE THERAPIES"
Description of Mark
The mark consists of the stylized letters SIO above the words GENE THERAPIES with a design of a double helix integrated within the O in SIO.
Goods and Services
Pharmaceutical preparations for human use used for the treatment of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders, excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and anti-aging and anti-wrinkle skin care prevention preparations and treatments; biologic preparations for medical and therapeutic purposes used for the treatment of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders, excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and anti-aging and anti-wrinkle skin care prevention preparations and treatments
Goods and Services
Scientific and technological services and research and design relating thereto in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; pharmaceutical, biomedical and biological therapeutic research services in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; pharmaceutical research and development in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; all of the foregoing excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and anti-aging and anti-wrinkle skin care prevention preparations and treatments
Goods and Services
Providing health and medical information; providing medical and health information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; all of the foregoing used for the treatment of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders, excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and antiaging and anti-wrinkle skin care prevention preparations and treatments
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2021-01-30
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2021-01-30
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2021-01-30
Primary Code
044
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Allison Strickland Ricketts
Address
Please log in with your Justia account to see this address.
Foreign Application Information
| Filing Date | Application Number | Country | Foreign Priority Claim In |
| 2020-06-12 | MU/M/2020/31431 | Mauritius | True |
Madrid International Filings
Entry Number
1
Reference Number
A0102648
Original Filing Date USPTO
2020-11-30
International Registration Number
1574191
International Registration Date
2020-11-30
International Status Code
480
International Renewal Date
2030-11-30
| Madrid History Events | ||
| Date | Code | Description |
| 2020-11-30 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
| 2020-12-07 | EPIAI | TEAS PETITION TO DIRECTOR TO REVIEW DENIAL OF IA |
| 2021-10-01 | ADDCH | CHANGE OF ADDRESS RECEIVED FROM IB |
| 2020-12-11 | PCGRO | PETITION TO DIRECTOR GRANTED |
| 2020-12-11 | RESTO | RESTORATION OF INTL APP AFTER INITIAL DEMISE |
| 2020-12-04 | NCERT | APPLICATION FOR IR REJECTED BY MPU |
| 2021-02-11 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
Trademark Events
| Event Date | Event Description |
| 2020-11-27 | NEW APPLICATION ENTERED IN TRAM |
| 2021-01-30 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2021-02-02 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 2021-05-08 | ASSIGNED TO EXAMINER |
| 2021-05-10 | NON-FINAL ACTION WRITTEN |
| 2021-05-10 | NON-FINAL ACTION E-MAILED |
| 2021-05-10 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2021-05-12 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2021-05-12 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2021-05-12 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2021-11-10 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-11-10 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-11-11 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-11-17 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-11-19 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| 2021-11-23 | ELECTRONIC RECORD REVIEW COMPLETE |
| 2021-12-08 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-12-28 | PUBLISHED FOR OPPOSITION |
| 2021-12-28 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2022-01-19 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| 2022-01-20 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| 2022-01-31 | ASSIGNED TO PETITION STAFF |
| 2022-02-01 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| 2022-02-01 | REVIEW OF CORRESPONDENCE COMPLETE |
